Parameters requested from individual studies
Parameter | Categories/unit | |
Demographics | Age* | years |
Gender* | M/F | |
Weight | kg | |
Height | m | |
BMI | kg/m² | |
Creatinine | mg/dL or µmol/L | |
Creatinine clearance* | mL/min | |
Diabetes mellitus | y/n | |
Liver disease | y/n | |
LVEF* | % | |
Euroscore 2 | ||
UFH or LMWH or fondaparinux (within 24 hours preop) | y/n | |
Procedural variables | Urgency* | Elective/urgent/emergency/salvage |
CABG indication | Stable CAD/NSTEMI/STEMI | |
CPB time | minutes | |
No of arterial grafts | ||
No of distal anastomoses | ||
Tranexamic acid during surgery | y/n | |
Hb preoperative | g/L | |
Platelets preoperative | x109/L | |
Institutional protocol for treating postpump bleeding | y/n | |
ASS perioperative continuation | y/n | |
ASS cessation prior to surgery | days | |
Clopidogrel preoperative | y/n | |
Clopidogrel cessation prior to surgery | days | |
Prasugrel preoperative | y/n | |
Prasugrel cessation prior to surgery | days | |
Ticagrelor preoperative | y/n | |
Ticagrelor cessation prior to surgery | days | |
Outcome | Chest tube drainage volume within 24 hours† | ml |
Reoperation due to bleeding | y/n | |
Intracranial bleeding within 48 hours perioperatively | y/n | |
No of transfused red blood cell units within 48 hours from incision | ||
Postoperative MI | y/n | |
In-hospital mortality | y/n | |
30-day mortality | y/n |
*Part of euroscore II.
†If unavailable chest tube drainage volume obtained during shorter observation period (define observation period).
ASS, Aspirin; BMI, body mass index; CABG, coronary artery bypass grafting; CAD, Coronary Artery Disease; CPB, Cardiopulmonary Bypass; Hb, Haemoglobin; LMWH, Low Molecular Weight Heparin; LVEF, Left ventricular ejection fraction ; MI, Myocardial infarction; NSTEMI, Non-ST-Elevation Myocardial Infarction; STEMI, ST-Elevation Myocardial Infarction; UFH, Unfractionated heparin.